105 results
Page 3 of 6
8-K
EX-99.1
2wrahdr2bmd76jkd
10 Aug 22
Pulse Biosciences Reports Second Quarter 2022 Financial Results
4:15pm
8-K
EX-99.1
99mzknccqzm ps4x
9 Jun 22
Pulse Biosciences, Inc. Announces the Closing of its Rights Offering
4:58pm
8-K
EX-99.1
5s7c swav24
3 Jun 22
Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering
4:05pm
SD
EX-1.01
luzrc l3r
31 May 22
Conflict minerals disclosure
4:07pm
8-K
EX-99.1
3ier7d7te fzhlwjxnjp
19 May 22
Pulse Biosciences, Inc. Announces Changes to its Rights Offering
8:28am
8-K
EX-99.1
38fkdyfy39
11 May 22
Pulse Biosciences Reports First Quarter 2022 Financial Results
4:21pm
424B5
mpy n0bc24y
4 May 22
Prospectus supplement for primary offering
8:40am
8-K
EX-99.7
fv2c ixgym4
4 May 22
Other Events
8:20am
8-K
EX-99.1
ewrex2 1wl
14 Apr 22
Pulse Biosciences, Inc. Announces Rights Offering
4:23pm
8-K
EX-99.1
i9t4g
31 Mar 22
Pulse Biosciences Reports Fourth Quarter & Full Year 2021 Financial Results
4:19pm
8-K
EX-99.1
uig3447zsjc0nqyn hz
15 Feb 22
Pulse Biosciences Announces the Appointment of Kevin Danahy as Chief Commercial Officer
9:26am
8-K
EX-99.1
qo4 fixfa
8 Feb 22
Pulse Biosciences Provides an Update on Recent FDA 510(k) Submission
8:58am
8-K
EX-99.1
cia7t4c18gtk
11 Jan 22
Pulse Biosciences Announces Preliminary Fourth Quarter and Full Year 2021 Financial and Operational Results
9:07am
8-K
EX-99.1
53it1qr2nm r1n
15 Nov 21
Pulse Biosciences Reports Third Quarter 2021 Financial Results
12:00am
8-K
EX-99.1
6p5b7tcm8yfj2ayi a60
6 Oct 21
Pulse Biosciences Appoints Laureen DeBuono to Its Board of Directors
9:02am
8-K
EX-99.1
brnklisx
20 Aug 21
Pulse Biosciences Announces Appointment of Mitchell E. Levinson as Chief Strategy Officer
4:11pm